Ajax Health

Ajax Health is a private equity and venture capital firm established in 2017, with headquarters in Menlo Park, California, and an additional office in New York City. The firm specializes in all stages of a company's lifecycle, focusing on innovative medical device companies, medtech, healthcare services, digital health, biotechnology, and healthcare IT. Ajax Health aims to accelerate medical innovation by investing in solutions that address significant challenges in the healthcare sector. Through its strategic investments, the firm seeks to foster advancements that improve patient outcomes and enhance care delivery.

12 past transactions

AcuityMD

Series A in 2022
AcuityMD develops a medical technology software platform for commercializing and improving medical devices with data. The platform brings clarity to the products used to treat patients, helping medical device companies expand access in their markets.

XII Medical

Series A in 2022
XII Medical is a medical device developer company. It develops a minimally invasive outpatient technology for the treatment of obstructive sleep apnea.

Third Harmonic Bio

Series B in 2022
Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, oral KIT inhibitor for treatment of severe allergy and inflammation. KIT is a cell surface receptor that acts as the master survival and functional regulator of mast cells, which are immune cells concentrated at the body’s interfaces with the external environment and that act as the key mediator of the inflammation associated with allergic diseases.

AcuityMD

Seed Round in 2021
AcuityMD develops a medical technology software platform for commercializing and improving medical devices with data. The platform brings clarity to the products used to treat patients, helping medical device companies expand access in their markets.

Treeline Biosciences

Series A in 2021
Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions. The company was founded in 2021 and is headquartered in Stamford, Connecticut.

Atriomx

Series A in 2020
Atriomx develops a solution that delivers deep electrophysiology insights via non-invasive clinical hardware. Atriomx is leveraging advanced data science to transform the way cardiac arrhythmias are understood and improve the way patients are treated - before they undergo costly and invasive treatments. Atriomx’s proprietary algorithms provide unparalleled insight into a patient’s disease state, giving doctors and patients the information they need in order to decide with confidence which treatment is right for each individual patient.

Protaryx Medical

Series A in 2020
Protaryx Medical is a medical device company committed to reimagining access to the left atrium for transcatheter cardiac procedures. Taking an innovative approach, Protaryx aims to deliver meaningful improvements for physicians and patients. The company is headquartered in Baltimore, Maryland, with engineering operations in Minneapolis, Minnesota.

Cortica

Venture Round in 2020
Cortica provides diagnoses for autism, ADHD, developmental delays, and developmental differences. They offer in-home, in-clinic, and telehealth services. Their services include gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, ABA therapy, parent coaching, speech-language therapy, occupational therapy, physical therapy, music therapy, and more.

Verix Health

Series A in 2019
Verix Health is developing a suite of actively steerable surgical devices enabling minimally invasive diagnosis and treatment of lesions in difficult-to-access anatomies. The company was founded by Professor Mark Yim, PhD and PCI Ventures at the University of Pennsylvania and incubated at the Pennovation Center in Philadelphia.

EPMap-System

Series A in 2019
More than 20 years experience in Electrophysiology of the Heart. They provide a new Product in a Electrophysiology, EPPerfect is a full integrated solution for a Recording, Stimulation, Navigation and Aplation of the Heart. EPPerfect can be also integrated with other Solution.

Ablacon

Series A in 2019
Ablacon has built a premier machine intelligence system to quantitatively and qualitatively understand and treat atrial fibrillation (AF).Their technology visualizes in real-time what is going on in the heart. They compute the electrographic flow which allows to treat atrial fibrillation faster, more precisely and more reliably.

EPIX Therapeutics

Venture Round in 2017
EPIX Therapeutics develops and manufactures products for use in electrophysiology based on microwave radiometry technology. Its products provide real-time feedback of energy delivered by catheters during cardiac ablation procedures. The company has a strategic relationship with Hansen Medical Inc. Advanced Cardiac Therapeutics, Inc. (ACT), a medical device company that designs and manufactures a catheter-based system for the treatment of patients with atrial fibrillation (AFIB), today announced it has changed its name to EPIX Therapeutics, Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.